Delivery of a budget
impact model to over 25 countries, which secured reimbursement in the
majority of these countries.
Development of a cost-effectiveness
analysis and adaptation to ten specific European markets for an
oncology product.
Support for 30 country affiliates in
adapting a cost-effectiveness analysis to their local market for a
product used in patients with renal dysfunction.
Completion of pricing and
reimbursement submissions in emerging markets for dialysis patients.
Preparation of payer value slide deck for an orphan drug in
hematology.
Economic
impact studies comparing the cost of medical resource utilization for
different treatment patterns for major depression disorder.
Creation of an evidence generation plan for oncology products in
Phase I, II, and III.
Organization of payer and health-economic expert advisory boards to
assess acceptability of data package, value messages.
Copyright 2010 International
Market Access Consulting. All rights reserved.